Nov 17, 2016 12:00pm EST Dermata Therapeutics, LLC Announces Initiation of Treatment in a Phase 2 Atopic Dermatitis Study
Sep 28, 2016 8:00am EDT Dermata Therapeutics, LLC Announces Positive Top-line Results from their Phase 1 Pharmacokinetic Study of DMT210 in Acne Rosacea Patients
Sep 20, 2016 8:00am EDT Dermata Therapeutics, LLC Announced the Addition of Wendell Wierenga, Ph.D. to its Board of Directors
May 16, 2016 8:00am EDT Dermata Therapeutics, LLC Announces Initiation of Phase 1 Pharmacokinetic Study
